Vanguard Personalized Indexing Management
UTHR icon

Vanguard Personalized Indexing Management’s United Therapeutics UTHR Stock Holding History

Vanguard Personalized Indexing Management’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.2M Sell
7,747
-62
-0.8% -$34.9K 0.03% 393
2026
Q1 		$4.63M Sell
7,809
-37
-0.5% -$18.4K 0.05% 336
2025
Q4 		$3.82M Sell
7,846
-251
-3% -$117K 0.04% 387
2025
Q3 		$3.39M Sell
8,097
-87
-1% -$29.3K 0.03% 410
2025
Q2 		$2.35M Buy
8,184
+1,170
+17% +$350K 0.03% 510
2025
Q1 		$2.16M Sell
7,014
-129
-2% -$44.2K 0.03% 474
2024
Q4 		$2.52M Buy
7,143
+303
+4% +$111K 0.04% 405
2024
Q3 		$2.45M Buy
6,840
+337
+5% +$114K 0.04% 401
2024
Q2 		$2.07M Buy
6,503
+1,187
+22% +$314K 0.04% 401
2024
Q1 		$1.22M Sell
5,316
-1,663
-24% -$375K 0.03% 567
2023
Q4 		$1.53M Buy
6,979
+602
+9% +$139K 0.04% 440
2023
Q3 		$1.44M Sell
6,377
-254
-4% -$58.5K 0.04% 409
2023
Q2 		$1.46M Buy
6,631
+328
+5% +$72.7K 0.04% 409
2023
Q1 		$1.41M Sell
6,303
-116
-2% -$28.6K 0.05% 392
2022
Q4 		$1.79M Buy
6,419
+44
+0.7% +$11.1K 0.07% 290
2022
Q3 		$1.33M Buy
6,375
+211
+3% +$47.2K 0.06% 342
2022
Q2 		$1.45M Buy
6,164
+3,692
+149% +$751K 0.07% 294
2022
Q1 		$444K Sell
2,472
-695
-22% -$132K 0.02% 872
2021
Q4 		$684K Buy
3,167
+1,124
+55% +$221K 0.04% 569
2021
Q3 		$377K Buy
2,043
+887
+77% +$175K 0.03% 665
2021
Q2 		$207K Buy
+1,156
New +$220K 0.02% 885

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Vanguard Personalized Indexing Management's UTHR Position: Q2 2026 in Review

Vanguard Personalized Indexing Management reduced its United Therapeutics (UTHR) stake by 0.79% in Q2 2026, selling an estimated $34.9K and leaving 7,747 shares worth $4.2M. The position accounts for 0.03% of the portfolio, ranked #393.

Vanguard Personalized Indexing Management first reported a position in UTHR in Q2 2021 and has held it in 21 quarters since. The position peaked at $4.63M in Q1 2026. 875 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • Vanguard Personalized Indexing Management held 7,747 shares of United Therapeutics worth $4.2M as of Q2 2026.
  • Vanguard Personalized Indexing Management sold 62 United Therapeutics shares in Q2 2026, an estimated $34.9K.
  • United Therapeutics made up 0.03% of Vanguard Personalized Indexing Management's portfolio in Q2 2026, its #393 holding.
  • Vanguard Personalized Indexing Management first reported a position in United Therapeutics in Q2 2021 and has held it in 21 quarters since.
  • Vanguard Personalized Indexing Management's United Therapeutics position peaked at $4.63M in Q1 2026.
  • 875 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on Vanguard Personalized Indexing Management's 13F filing for Q2 2026, filed 11 Aug 2026.